Related Experiment Video
Updated: Jul 4, 2026

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
Published on: April 29, 2015
Design opportunities for actively targeted nanoparticle vaccines
Tarek M Fahmy1, Stacey L Demento, Michael J Caplan
1Yale University, Department of Biomedical Engineering, USA. tarek.fahmy@yale.edu
Nanoparticle technology offers a systematic approach to overcome challenges in vaccine development. This modular system optimizes vaccine design for improved immune responses against infectious diseases and cancer.
Area of Science:
- Biotechnology
- Immunology
- Materials Science
Background:
- Many vaccines for infectious diseases are underdeveloped or unavailable due to technological and design challenges.
- A systematic approach is needed to address these complex vaccine design issues.
Purpose of the Study:
- To review technological variables and design parameters for modular nanoparticle vaccine systems.
- To explore how nanoparticle technology can optimize vaccine development for infectious diseases and cancer.
Main Methods:
- Review of existing literature on nanoparticle vaccine systems.
- Discussion of key design variables including core matrix properties, surface modifications, and administration routes.
Main Results:
- Nanoparticle technology allows for systematic testing of individual or combined design variables.
- Optimization of nanoparticle characteristics can lead to enhanced immune responses.
Conclusions:
- Modular nanoparticle vaccine systems present a promising strategy for overcoming current vaccine development hurdles.
- Tailoring nanoparticle design is crucial for effective protection against infectious diseases and cancer.
More Related Videos
10:58Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
Related Concept Videos
Modified-Release Drug Delivery Systems: Site-Targeted
Site-Targeted Drug Delivery Systems: Polymeric Carriers